市場調查報告書
商品編碼
785796

止咳藥的全球市場 - 市場規模,佔有率,預測,市場機會分析 2018年∼2026年

Cough Suppressant Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

咳嗽,是各種上呼吸道感染及下呼吸道感染疾病的最常見的症狀。由於主要製藥企業止咳藥持續登場,在預測期間中預計促進止咳藥市場成長。主要企業的研究和安全性及有效性的評估,起因於高患病率的止咳藥需求增加等也成為市場成長要素。

本報告提供止咳藥的世界市場調查,市場概要,各疾病、醫藥品、產品、年齡層、劑型、流通管道、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告概要
  • 市場定義和範圍
  • 摘要整理
  • 市場片段:各疾病
  • 市場片段:各類醫藥品
  • 市場片段:各產品
  • 市場片段:各年齡層
  • 市場片段:各劑型
  • 市場片段:各流通管道
  • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

    • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析
    • 新產品的銷售/核准
    • 合併收購方案
    • PEST分析
    • 波特的五力分析
    • 法規方案
    • 償付方案
    • 流行病學

第4章 全球止咳藥市場:各疾病

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
    • 市場區隔趨勢
  • 乾咳
  • 濕咳

第5章 全球止咳藥市場:各類醫藥品

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
    • 市場區隔趨勢
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • 其他

第6章 全球止咳藥市場:各產品

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
    • 市場區隔趨勢
  • 成藥
  • 處方醫藥品

第7章 全球止咳藥市場:各年齡層

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
    • 市場區隔趨勢
  • 兒童
  • 成人

第8章 全球止咳藥市場:各流通管道

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
    • 市場區隔趨勢
  • 醫院
  • 零售藥局
  • 線上藥局
  • 其他

第9章 全球止咳藥市場:各地區

  • 簡介
    • 市場佔有率分析(成果值、預測值)
    • 與前一年同期比較成長率分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第10章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Perrigo Company plc.
    • Vernalis plc.
    • Tris Pharma Inc.
    • Pfizer, Inc.
    • Aytu BioScience, Inc.
    • Acella Pharmaceuticals LLC
    • Mayne Pharma Inc.
    • Taro Pharmaceutical Industries Ltd
    • Amneal Pharmaceuticals LLC
    • Aurobindo Pharma Ltd
    • GlaxoSmithKline plc.

第11章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Research
目錄

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market.

Market Dynamics

Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive.

Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs.

For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial.

Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly.

Key features of the study:

  • This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global cough suppressant drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market

Detailed Segmentation:

  • Global Cough Suppressant Drugs Market, By Disease Type :
    • Dry Cough
    • Wet Cough
  • Global Cough Suppressant Drugs Market, By Drug Type :
    • Dextromethorphan
    • Codeine
    • Noscapine
    • Butamirate
    • Benzonatate
    • Pholcodine
    • Others
  • Global Cough Suppressant Drugs Market, By Age Group:
    • Pediatric
    • Adult
  • Global Cough Suppressant Drugs Market, By Dosage Form:
    • Syrup
    • Tablet
    • Others
  • Global Cough Suppressant Drugs Market, By Distribution Channel:
    • Hospital
    • Retail Pharmacy
    • Online Pharmacy
    • Others
  • Global Cough Suppressant Drugs Market, By Region:
    • North America
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Disease Type :
      • Dry Cough
      • Wet Cough
      • By Drug Type:
      • Dextromethorphan
      • Codeine
      • Noscapine
      • Butamirate
      • Benzonatate
      • Pholcodine
      • Others
      • By Product Type
      • Over-the-counter (OTC)
      • Prescription Drug
      • By Age Group
      • Pediatric
      • Adult
      • By Dosage Form
      • Syrup
      • Tablet
      • Others
      • By Distribution Channel
      • Hospital
      • Retail Pharmacy
      • Online Pharmacy
      • Others
      • By Country:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Perrigo Company plc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Vernalis plc.
    • Tris Pharma Inc.
    • Pfizer Inc.
    • Aytu BioScience, Inc.
    • Acella Pharmaceuticals LLC
    • Mayne Pharma Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals LLC
    • Aurobindo Pharma Ltd.
    • GlaxoSmithKline plc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Disease Type
    • Market Snippet, By Drug Type
    • Market Snippet, By Product Type
    • Market Snippet, By Age Group
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • Merger-Acquisition Scenario
    • PEST Analysis
    • PORTER's Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology

4. Global Cough Suppressant Drugs Market, By Disease Type, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Dry Cough
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Wet Cough
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Cough Suppressant Drugs Market, By Drug Type, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Dextromethorphan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Codeine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Noscapine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Butamirate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Benzonatate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Pholcodine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Cough Suppressant Drugs Market, By Product Type, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Over-the-counter (OTC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Prescription Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Cough Suppressant Drugs Market, By Age Group, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

9. Global Cough Suppressant Drugs Market, By Region, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
    • Latin America
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

10. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Perrigo Company plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Vernalis plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Tris Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aytu BioScience, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Acella Pharmaceuticals LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Mayne Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Taro Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Amneal Pharmaceuticals LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aurobindo Pharma Ltd
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Section

    • References
    • Research Methodology
    • About us and Sales Contact